Aktis Oncology, Inc.
AKTS
$25.00
$0.281.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Revenue | 3.38M | 3.23M | 1.87M | 1.60M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 3.38M | 3.23M | 1.87M | 1.60M | |
| Cost of Revenue | 25.28M | 20.04M | 16.49M | 18.63M | |
| Gross Profit | -21.90M | -16.81M | -14.62M | -17.03M | |
| SG&A Expenses | 7.00M | 5.90M | 2.75M | 3.94M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 32.28M | 25.93M | 19.25M | 22.56M | |
| Operating Income | -28.90M | -22.71M | -17.38M | -20.96M | |
| Income Before Tax | -24.14M | -18.33M | -15.14M | -18.08M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -24.14M | -18.33M | -15.14M | -18.08M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -24.14M | -18.33M | -15.14M | -18.08M | |
| EBIT | -28.90M | -22.71M | -17.38M | -20.96M | |
| EBITDA | -28.02M | -22.05M | -16.68M | -20.41M | |
| EPS Basic | -0.44 | -0.38 | -18.21 | -22.39 | |
| Normalized Basic EPS | -0.27 | -0.24 | -11.38 | -13.99 | |
| EPS Diluted | -0.44 | -0.38 | -18.21 | -22.39 | |
| Normalized Diluted EPS | -0.27 | -0.24 | -11.38 | -13.99 | |
| Average Basic Shares Outstanding | 55.30M | 48.63M | 831.20K | 807.30K | |
| Average Diluted Shares Outstanding | 55.30M | 48.63M | 831.20K | 807.30K | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |